Refine
Has Fulltext
- yes (149) (remove)
Is part of the Bibliography
- yes (149)
Year of publication
Document Type
- Journal article (146)
- Report (2)
- Review (1)
Language
- English (149) (remove)
Keywords
- Neurobiologie (41)
- Medizin (9)
- glioblastoma (8)
- astrocytoma (5)
- glioblastoma multiforme (5)
- Durchblutung (4)
- Gehirn (4)
- active zone (4)
- brain (4)
- deep brain stimulation (4)
- rats (4)
- recurrence (4)
- therapy (4)
- vestibular schwannoma (4)
- Glioblastoma (3)
- Hypothalamus (3)
- Parkinson's disease (3)
- Prostaglandine (3)
- TRH (3)
- blood pressure (3)
- brain tumor (3)
- mRNA (3)
- meningioma (3)
- metabolism (3)
- mice (3)
- neuroprotection (3)
- protein (3)
- relapse (3)
- subthalamic nucleus (3)
- traumatic brain injury (3)
- CNS disorders (2)
- COVID-19 (2)
- Lipopolysaccharide (2)
- MPS1 (2)
- Mesenteric circulation (2)
- Neurophysiologie (2)
- Parkinson’s disease (2)
- SAH (2)
- Stroke (2)
- Tumor Treating Fields (TTFields) (2)
- blood-brain barrier (2)
- blood–brain barrier (2)
- cancer stem cells (2)
- cardiac output (2)
- closed head injury (2)
- contact-kinin system (2)
- depression (2)
- dopamine (2)
- expression (2)
- factor XII (2)
- fluoroscopy (2)
- glioma (2)
- heart rate (2)
- imaging (2)
- inflammation (2)
- intraoperative imaging (2)
- local field potentials (2)
- low-grade glioma (2)
- mRNA expression (2)
- organoids (2)
- pathogenesis (2)
- radiotherapy (2)
- temozolomide (2)
- tumor necrosis factor (2)
- 2 PM (1)
- 2-photon microscopy (1)
- 3 D rotational fluoroscopy (1)
- 3D ex vivo models (1)
- 3D fluoroscopy (1)
- 3D in vitro model (1)
- ADAM9 (1)
- Anaphylactic shock (1)
- Anaphylaxis (1)
- Astrocytic tumor (1)
- Autoradiography (1)
- Axonal degeneration (1)
- BN 52021 (1)
- Bevacizumab (1)
- Biowissenschaften (1)
- Blood–brain barrier (1)
- Blutdruck (1)
- Bone chips (1)
- Brain stem (1)
- Bruchpilot (1)
- C1-inhibitor (1)
- CA2+ channels (1)
- CA3 (1)
- CA3 pyrimidal cells (1)
- CBF (1)
- CD133 (1)
- CNS cancer (1)
- CNS diseases (1)
- CRPS (1)
- CSVD (1)
- CX3CL1 (1)
- CXCL13 (1)
- CXCR4 (1)
- Cardiovascular (1)
- Cardiovascular system (1)
- Cerebral Ischemia (1)
- Cerebral-ischemia (1)
- Cranial window (1)
- Crespi effect (1)
- DBS biomarkers (1)
- DBS programming (1)
- Delayed cerebral infarction (1)
- Delayed ischemic neurological deficit (1)
- Drosophila melanogaster (1)
- E-cadherin (1)
- ED2 (1)
- Endothelial cell (1)
- Endothelium (1)
- Endothelzelle (1)
- Expression (1)
- Fibrin glue (1)
- Fluorescence (1)
- Focal brain ischemia (1)
- Glioblastom (1)
- Glioblastoma cell line (1)
- Glioblastoma multiforme (1)
- Glioblastomas (1)
- Glioma stem cells (1)
- HBO (1)
- HERV-K (1)
- Head-injury (1)
- Hemodynamic depression (1)
- Hemorrhage (1)
- Human endogenous retrovirus (1)
- Hypertension (1)
- IBA-1 (1)
- IDH (1)
- IDH1/2 (1)
- IL-6 (1)
- ISBI (1)
- Icosanoid (1)
- Immunostimulatory adjuvant (1)
- Immunotherapy (1)
- In vitro models (1)
- In vivo imaging (1)
- In-vivo dia lysis (1)
- IntelliCage (1)
- Intercellular adhesion molecule 1 (1)
- Intravascular coagulation (1)
- Intravital imaging (1)
- Irradiation (1)
- KIF (1)
- KIF11 (1)
- Lateral suboccipital craniectomy (1)
- Lipoxin (1)
- Locus coeruleus (1)
- MGMT (1)
- MGMT promoter methylation (1)
- MMP9 (1)
- Merlin (1)
- Metalloproteinasen (1)
- Metastatic breast cancer (1)
- Mice (1)
- Microinjection (1)
- Model (1)
- Molecular-weight heparin (1)
- Monocyte (1)
- Mouse model (1)
- N-Acetyl-leukotriene E4 (1)
- NADPH oxidases (NOX) (1)
- NCH93 (1)
- NF2-related schwannomatosis (NF2) (1)
- Nestin (1)
- Neurons (1)
- Neuropeptides (1)
- Neuroprotection (1)
- Oncolysis (1)
- Osteogeneration (1)
- Osteopontin (1)
- PAF-acether (1)
- PCDHGC3 (1)
- PCR analysis (1)
- PDH (1)
- PET (1)
- PET/CT (1)
- PFA in ethanol (1)
- Pentixafor (1)
- Peptide-leukotrienes (1)
- Phase II trials (1)
- Physiologie (1)
- Prostaglandins (1)
- R-715 (1)
- RECK (1)
- RIM-binding protein (1)
- RIM1α (1)
- RS-13 (1)
- Rat hippocampus (1)
- Rats (1)
- Renal circulation (1)
- Reperfusion (1)
- SARS-CoV-2 (1)
- SHRSP (1)
- SOAT1 (1)
- SV pool (1)
- Silver degeneration staining (1)
- Spinal dissemination (1)
- Staphylococcus (1)
- Subarachnoid hemorrhage (1)
- Supraoptic nucleus (1)
- Surgery (1)
- Sympathetic nervous system (1)
- T-2 toxin (1)
- TBI (1)
- TNF-α (1)
- TSPO (1)
- TTFields (1)
- TTK (1)
- Temozolomide (1)
- Thromboplastin (1)
- Thrombus formation (1)
- Thyreotropin-Releasinghormon (1)
- Trauma (1)
- Tumor-Treating Fields (TTFields) (1)
- VLSM (1)
- Vasopressin (1)
- Ventilation (1)
- Von Willebrand factor (1)
- WNT signaling (1)
- Willebrand-Faktor (1)
- Zell-Adhäsionsmolekül (1)
- [3H][3Me-His2]-TRH (1)
- \(^{68}\)Ga-Pentixafor (1)
- accelerator based radiosurgery (1)
- acoustic startle (1)
- acute brain slices (1)
- adherence (1)
- adolescence (1)
- aerobic glycolysis (1)
- aging (1)
- alkaline phosphatase (1)
- amplitude criterion (1)
- amyloidoma (1)
- anaplastic medulloblastoma (1)
- aneurysm (1)
- animal model (1)
- anticancer activity (1)
- anxiety (1)
- asfotase alfa (1)
- astrocytes (1)
- astrocytic tumor (1)
- astroglia (1)
- atrial fibrillation (1)
- audiometry (1)
- autoradiography (1)
- behavior (1)
- benzodiazepine antagonist. (1)
- beta oscillations (1)
- beta power (1)
- beta-catenin (1)
- blastocysts (1)
- blood brain barrier (1)
- blood nerve barrier (1)
- blood-brain-barrier (1)
- bradykinin (1)
- brain development (1)
- brain edema (1)
- brain-injury (1)
- brainstem auditory evoked potentials (1)
- cancer (1)
- catecholamlnes (1)
- cerebEND (1)
- cerebEND cells (1)
- cerebraI ischemia (1)
- cerebrovascular disorders (1)
- cervical spine (1)
- chemokine receptor-4 (1)
- chemotherapy (1)
- childhood (1)
- children (1)
- chlorisondamine (1)
- chronic heart failure (1)
- chronic stimulation (1)
- claudin-1 (1)
- clinical trials (1)
- cognitive function (1)
- cognitive functions (1)
- coherence analysis (1)
- compaction (1)
- craniofacial orthodontics (1)
- craniovertebral junction (1)
- cytokines (1)
- dSTORM (1)
- damage control orthopedics (1)
- deafness (1)
- deformational cranial asymmetry (1)
- dennorphin (1)
- derivation (1)
- dermorphin (1)
- dexamethasone (1)
- differentiation (1)
- diffuse (1)
- diffuse astrocytoma (1)
- direct cortical stimulation (1)
- directional deep brain stimulation (1)
- distress (1)
- double-blind (1)
- early brain injury (1)
- edema (1)
- electron tomography (1)
- executive function (1)
- experimental stroke (1)
- expression pattern (1)
- femoral fracture (1)
- flumazenil (1)
- focal (1)
- focal brain lesion (1)
- focal cerebral-ischemia (1)
- frameless systems (1)
- gamma knife radiosurgery (1)
- glioblastoma cell-lines (1)
- glioblastoma multiforme (GBM) (1)
- glucocorticoid receptor (1)
- group 3 (1)
- guidelines (1)
- head (1)
- hearing preservation (1)
- hemorrhagic shock (1)
- high-pressure freezing (1)
- high-pressure freezing/freeze substitution (1)
- hippocampal (1)
- hippocampal mossy fiber bouton (1)
- homeostasis (1)
- human brain microvascular endothelial cells (HBMVEC) (1)
- human cells (1)
- hypophosphatasia (1)
- hypovolemic hypotension (1)
- hypoxia (1)
- image-guided programming (1)
- immunofluorescence (1)
- immunofuorescence double staining (1)
- immunohistochemistry (1)
- in vitro model (1)
- in vivo (1)
- in-vitro (1)
- in-vivo (1)
- infants with deformational plagiocephaly (DP) (1)
- inflammatory mechanisms (1)
- integrin (1)
- internalized stigmatization (1)
- intraoperative monitoring (1)
- ischemia (1)
- isosteviol sodium (1)
- isosteviol sodium (STVNA) (1)
- kallikrein–kinin system (1)
- kinesin (1)
- kinin receptor (1)
- kinin receptors (1)
- knock down (1)
- lesion symptom mapping (1)
- lines (1)
- lipid droplets (1)
- liponeurocytoma (1)
- lipopolysaccharides (1)
- liquid biopsy (1)
- lnflammation (1)
- locus coeruleus (1)
- lower grade glioma (1)
- macrophages (1)
- management (1)
- matrix metalloproteinase (1)
- mechanism of action (1)
- medulloblastoma (1)
- memory (1)
- metastasis (1)
- metastasis associated in colorectal cancer 1 (MACC1) (1)
- metastasis-associated in colon cancer 1 (MACC1) (1)
- methylation (1)
- methylprednisolone (1)
- microRNA (1)
- microglia (1)
- minimally invasive (1)
- minocycline (1)
- mitotane (1)
- modulation (1)
- molecular imaging (1)
- molecular signature (1)
- mononuclear phagocytes (1)
- mortality (1)
- mossy fiber synapses (1)
- motor control (1)
- mouse-brain (1)
- movement (1)
- movement disorders (1)
- multifocal growth (1)
- multiple sclerosis (1)
- mycotoxin (1)
- myocardial infarction (1)
- naloxonazine (1)
- naloxone (1)
- nanotopology (1)
- nausea and emesis (1)
- nervous-sytem (1)
- neural stem-cells (1)
- neurocytoma (1)
- neurodegenerative disease (1)
- neurofibromatosis type 2 (1)
- neuroinflammation (1)
- neurological complications (1)
- neurology (1)
- neuromuscular junction (1)
- neuronal damage (1)
- neuronavigation (1)
- neurooncology (1)
- neuropathic pain (1)
- neurosurgery (1)
- neurovascular disorders (1)
- neurovascular unit (1)
- non-VKA oral anticoagulants (1)
- non-small cell lung cancer (NSCLC) (1)
- nucleus (1)
- object recognition memory (1)
- obsessive-compulsive disorder (1)
- occupation (1)
- oligodendroglioma (1)
- opiates (1)
- opioid peptides (1)
- opioid receptors (1)
- opioid-benzodiazepine interactions (1)
- organotypic hippocampal slice cultures (OHSC) (1)
- orthotopic xenograft (1)
- osteomalacia (1)
- ovarian cancer (1)
- oxidative stress (1)
- paediatric cancer (1)
- pain (1)
- palladium (1)
- pancreatic cancer (1)
- paragangliomas (1)
- pedicle screws (1)
- peptide receptor radionuclide therapy (PRRT) (1)
- physical examination (1)
- plasticity (1)
- platelet activating factor (1)
- platelet-activating factor (1)
- platform (1)
- platinum (1)
- pluripotent (1)
- positionalskull deformities (1)
- positron emission tomography/computed tomography (1)
- presynaptic (1)
- presynaptic plasticity (1)
- prevention (1)
- primary cell culture (1)
- progenitors (1)
- prognostic marker (1)
- prostacyclins (1)
- proteins (1)
- psychiatric disorders (1)
- pyramidal neurons (1)
- quality of life (1)
- radiation therapy (1)
- randomized controlled double-blind study (1)
- rare bone disease (1)
- rat (1)
- recombinat-human-erythropoietin (1)
- reflex (1)
- regional blood flow (1)
- regional blood ftow (1)
- release (1)
- renin (1)
- resilience (1)
- resistance (1)
- respiration (1)
- reveals (1)
- rickets (1)
- scale (1)
- schizophrenia (1)
- secondary brain damage (1)
- senescence (1)
- serotonin (1)
- shock (1)
- skull base (1)
- slice culture (1)
- specification (1)
- spinal tumor operation (1)
- spine (1)
- stereotaxy (1)
- stress (1)
- stroke (1)
- stroke therapy (1)
- subarachnoid hemorrhage (1)
- subarachnoid hemorrhage (SAH) (1)
- subjective perception (1)
- super-resolution microscopy (1)
- suppressor (1)
- surgery (1)
- sympathetic nerve activity. (1)
- synaptic ultrastructure (1)
- tPA (1)
- targeted therapy (1)
- taxanes (1)
- temporal bone (1)
- therapy response (1)
- thiosemicarbazone (1)
- three-dimensional (1)
- three-dimensional imaging (1)
- threshold criterion (1)
- threshold level (1)
- thromboinflammation (1)
- thrombosis (1)
- total peripheral resistance (1)
- transcranial motor-evoked potentials (1)
- transient ischemic attack (1)
- tumor slice cultures (1)
- tumor-necrosis-factor (1)
- tumormicroenvironment (1)
- vasopressin (1)
- vertebral pedicles (1)
- vitamin K antagonists (1)
- von Willebrand factor (1)
- warfarin (1)
- weight drop (1)
- µ opioid receptors (1)
- µ·Opioid receptor subtypes (1)
- β-APP (1)
Institute
- Neurochirurgische Klinik und Poliklinik (149) (remove)
Vestibular schwannoma (VS) are benign cranial nerve sheath tumors of the vestibulocochlear nerve. Their incidence is mostly sporadic, but they can also be associated with NF2-related schwannomatosis (NF2), a hereditary tumor syndrome. Metastasis associated in colon cancer 1 (MACC1) is known to contribute to angiogenesis, cell growth, invasiveness, cell motility and metastasis of solid malignant cancers. In addition, MACC1 may be associated with nonsyndromic hearing impairment. Therefore, we evaluated whether MACC1 may be involved in the pathogenesis of VS. Sporadic VS, recurrent sporadic VS, NF2-associated VS, recurrent NF2-associated VS and healthy vestibular nerves were analyzed for MACC1 mRNA and protein expression by quantitative polymerase chain reaction and immunohistochemistry. MACC1 expression levels were correlated with the patients’ clinical course and symptoms. MACC1 mRNA expression was significantly higher in sporadic VS compared to NF2-associated VS (p < 0.001). The latter expressed similar MACC1 concentrations as healthy vestibular nerves. Recurrent tumors resembled the MACC1 expression of the primary tumors. MACC1 mRNA expression was significantly correlated with deafness in sporadic VS patients (p = 0.034). Therefore, MACC1 might be a new molecular marker involved in VS pathogenesis.
Background
Hematogenous tumor spread of malignant meningiomas occurs very rarely but is associated with very poor prognosis.
Case presentation
We report an unusual case of a patient with a malignant meningioma who developed multiple metastases in bones, lungs and liver after initial complete resection of the primary tumor. After partial hepatic resection, specimens were histologically analyzed, and a complete loss of E-cadherin adhesion molecules was found. No oncogenic target mutations were found. The patient received a combination of conventional radiotherapy and peptide receptor radionuclide therapy (PRRT). Due to aggressive tumor behavior and rapid spread of metastases, the patient deceased after initiation of treatment.
Conclusions
E-cadherin downregulation is associated with a higher probability of tumor invasion and distant metastasis formation in malignant meningioma. Up to now, the efficacy of systemic therapy, including PRRT, is very limited in malignant meningioma patients.
Highlights
• Beta-Guided programming is an innovative approach that may streamline the programming process for PD patients with STN DBS.
• While preliminary findings from our study suggest that Beta Titration may potentially mitigate STN overstimulation and enhance symptom control,
• Our results demonstrate that beta-guided programming significantly reduces programming time, suggesting it could be efficiently integrated into routine clinical practice using a commercially available patient programmer.
Background
Subthalamic nucleus deep brain stimulation (STN-DBS) is an effective treatment for advanced Parkinson's disease (PD). Clinical outcomes after DBS can be limited by poor programming, which remains a clinically driven, lengthy and iterative process. Electrophysiological recordings in PD patients undergoing STN-DBS have shown an association between STN spectral power in the beta frequency band (beta power) and the severity of clinical symptoms. New commercially-available DBS devices now enable the recording of STN beta oscillations in chronically-implanted PD patients, thereby allowing investigation into the use of beta power as a biomarker for DBS programming.
Objective
To determine the potential advantages of beta-guided DBS programming over clinically and image-guided programming in terms of clinical efficacy and programming time.
Methods
We conducted a randomized, blinded, three-arm, crossover clinical trial in eight Parkinson's patients with STN-DBS who were evaluated three months after DBS surgery. We compared clinical efficacy and time required for each DBS programming paradigm, as well as DBS parameters and total energy delivered between the three strategies (beta-, clinically- and image-guided).
Results
All three programming methods showed similar clinical efficacy, but the time needed for programming was significantly shorter for beta- and image-guided programming compared to clinically-guided programming (p < 0.001).
Conclusion
Beta-guided programming may be a useful and more efficient approach to DBS programming in Parkinson's patients with STN-DBS. It takes significantly less time to program than traditional clinically-based programming, while providing similar symptom control. In addition, it is readily available within the clinical DBS programmer, making it a valuable tool for improving current clinical practice.
Purpose
Diaschisis of cerebrocerebellar loops contributes to cognitive and motor deficits in pediatric cerebellar brain tumor survivors. We used a cerebellar white matter atlas and hypothesized that lesion symptom mapping may reveal the critical lesions of cerebellar tracts.
Methods
We examined 31 long-term survivors of pediatric posterior fossa tumors (13 pilocytic astrocytoma, 18 medulloblastoma). Patients underwent neuronal imaging, examination for ataxia, fine motor and cognitive function, planning abilities, and executive function. Individual consolidated cerebellar lesions were drawn manually onto patients’ individual MRI and normalized into Montreal Neurologic Institute (MNI) space for further analysis with voxel-based lesion symptom mapping.
Results
Lesion symptom mapping linked deficits of motor function to the superior cerebellar peduncle (SCP), deep cerebellar nuclei (interposed nucleus (IN), fastigial nucleus (FN), ventromedial dentate nucleus (DN)), and inferior vermis (VIIIa, VIIIb, IX, X). Statistical maps of deficits of intelligence and executive function mapped with minor variations to the same cerebellar structures.
Conclusion
We identified lesions to the SCP next to deep cerebellar nuclei as critical for limiting both motor and cognitive function in pediatric cerebellar tumor survivors. Future strategies safeguarding motor and cognitive function will have to identify patients preoperatively at risk for damage to these critical structures and adapt multimodal therapeutic options accordingly.
Introduction
In spinal surgery, precise instrumentation is essential. This study aims to evaluate the accuracy of navigated, O-arm-controlled screw positioning in thoracic and lumbar spine instabilities.
Materials and methods
Posterior instrumentation procedures between 2010 and 2015 were retrospectively analyzed. Pedicle screws were placed using 3D rotational fluoroscopy and neuronavigation. Accuracy of screw placement was assessed using a 6-grade scoring system. In addition, screw length was analyzed in relation to the vertebral body diameter. Intra- and postoperative revision rates were recorded.
Results
Thoracic and lumbar spine surgery was performed in 285 patients. Of 1704 pedicle screws, 1621 (95.1%) showed excellent positioning in 3D rotational fluoroscopy imaging. The lateral rim of either pedicle or vertebral body was protruded in 25 (1.5%) and 28 screws (1.6%), while the midline of the vertebral body was crossed in 8 screws (0.5%). Furthermore, 11 screws each (0.6%) fulfilled the criteria of full lateral and medial displacement. The median relative screw length was 92.6%. Intraoperative revision resulted in excellent positioning in 58 of 71 screws. Follow-up surgery due to missed primary malposition had to be performed for two screws in the same patient. Postsurgical symptom relief was reported in 82.1% of patients, whereas neurological deterioration occurred in 8.9% of cases with neurological follow-up.
Conclusions
Combination of neuronavigation and 3D rotational fluoroscopy control ensures excellent accuracy in pedicle screw positioning. As misplaced screws can be detected reliably and revised intraoperatively, repeated surgery for screw malposition is rarely required.
Traumatic brain injury (TBI) is the leading cause of death and disability in polytrauma and is often accompanied by concomitant injuries. We conducted a retrospective matched-pair analysis of data from a 10-year period from the multicenter database TraumaRegister DGU\(^®\) to analyze the impact of a concomitant femoral fracture on the outcome of TBI patients. A total of 4508 patients with moderate to critical TBI were included and matched by severity of TBI, American Society of Anesthesiologists (ASA) risk classification, initial Glasgow Coma Scale (GCS), age, and sex. Patients who suffered combined TBI and femoral fracture showed increased mortality and worse outcome at the time of discharge, a higher chance of multi-organ failure, and a rate of neurosurgical intervention. Especially those with moderate TBI showed enhanced in-hospital mortality when presenting with a concomitant femoral fracture (p = 0.037). The choice of fracture treatment (damage control orthopedics vs. early total care) did not impact mortality. In summary, patients with combined TBI and femoral fracture have higher mortality, more in-hospital complications, an increased need for neurosurgical intervention, and inferior outcome compared to patients with TBI solely. More investigations are needed to decipher the pathophysiological consequences of a long-bone fracture on the outcome after TBI.
The metastatic suppressor BRMS1 interacts with critical steps of the metastatic cascade in many cancer entities. As gliomas rarely metastasize, BRMS1 has mainly been neglected in glioma research. However, its interaction partners, such as NFκB, VEGF, or MMPs, are old acquaintances in neurooncology. The steps regulated by BRMS1, such as invasion, migration, and apoptosis, are commonly dysregulated in gliomas. Therefore, BRMS1 shows potential as a regulator of glioma behavior. By bioinformatic analysis, in addition to our cohort of 118 specimens, we determined BRMS1 mRNA and protein expression as well as its correlation with the clinical course in astrocytomas IDH mutant, CNS WHO grade 2/3, and glioblastoma IDH wild-type, CNS WHO grade 4. Interestingly, we found BRMS1 protein expression to be significantly decreased in the aforementioned gliomas, while BRMS1 mRNA appeared to be overexpressed throughout. This dysregulation was independent of patients’ characteristics or survival. The protein and mRNA expression differences cannot be finally explained at this stage. However, they suggest a post-transcriptional dysregulation that has been previously described in other cancer entities. Our analyses present the first data on BRMS1 expression in gliomas that can provide a starting point for further investigations.
While glioblastoma (GBM) is still challenging to treat, novel immunotherapeutic approaches have shown promising effects in preclinical settings. However, their clinical breakthrough is hampered by complex interactions of GBM with the tumor microenvironment (TME). Here, we present an analysis of TME composition in a patient-derived organoid model (PDO) as well as in organotypic slice cultures (OSC). To obtain a more realistic model for immunotherapeutic testing, we introduce an enhanced PDO model. We manufactured PDOs and OSCs from fresh tissue of GBM patients and analyzed the TME. Enhanced PDOs (ePDOs) were obtained via co-culture with PBMCs (peripheral blood mononuclear cells) and compared to normal PDOs (nPDOs) and PT (primary tissue). At first, we showed that TME was not sustained in PDOs after a short time of culture. In contrast, TME was largely maintained in OSCs. Unfortunately, OSCs can only be cultured for up to 9 days. Thus, we enhanced the TME in PDOs by co-culturing PDOs and PBMCs from healthy donors. These cellular TME patterns could be preserved until day 21. The ePDO approach could mirror the interaction of GBM, TME and immunotherapeutic agents and may consequently represent a realistic model for individual immunotherapeutic drug testing in the future.
Non-small cell lung cancer, ovarian cancer, and pancreatic cancer all present with high morbidity and mortality. Systemic chemotherapies have historically been the cornerstone of standard of care (SOC) regimens for many cancers, but are associated with systemic toxicity. Multimodal treatment combinations can help improve patient outcomes; however, implementation is limited by additive toxicities and potential drug–drug interactions. As such, there is a high unmet need to develop additional therapies to enhance the efficacy of SOC treatments without increasing toxicity. Tumor Treating Fields (TTFields) are electric fields that exert physical forces to disrupt cellular processes critical for cancer cell viability and tumor progression. The therapy is locoregional and is delivered noninvasively to the tumor site via a portable medical device that consists of field generator and arrays that are placed on the patient’s skin. As a noninvasive treatment modality, TTFields therapy-related adverse events mainly consist of localized skin reactions, which are manageable with effective acute and prophylactic treatments. TTFields selectively target cancer cells through a multi-mechanistic approach without affecting healthy cells and tissues. Therefore, the application of TTFields therapy concomitant with other cancer treatments may lead to enhanced efficacy, with low risk of further systemic toxicity. In this review, we explore TTFields therapy concomitant with taxanes in both preclinical and clinical settings. The summarized data suggest that TTFields therapy concomitant with taxanes may be beneficial in the treatment of certain cancers.
Single-molecule localization microscopy (SMLM) greatly advances structural studies of diverse biological tissues. For example, presynaptic active zone (AZ) nanotopology is resolved in increasing detail. Immunofluorescence imaging of AZ proteins usually relies on epitope preservation using aldehyde-based immunocompetent fixation. Cryofixation techniques, such as high-pressure freezing (HPF) and freeze substitution (FS), are widely used for ultrastructural studies of presynaptic architecture in electron microscopy (EM). HPF/FS demonstrated nearer-to-native preservation of AZ ultrastructure, e.g., by facilitating single filamentous structures. Here, we present a protocol combining the advantages of HPF/FS and direct stochastic optical reconstruction microscopy (dSTORM) to quantify nanotopology of the AZ scaffold protein Bruchpilot (Brp) at neuromuscular junctions (NMJs) of Drosophila melanogaster. Using this standardized model, we tested for preservation of Brp clusters in different FS protocols compared to classical aldehyde fixation. In HPF/FS samples, presynaptic boutons were structurally well preserved with ~22% smaller Brp clusters that allowed quantification of subcluster topology. In summary, we established a standardized near-to-native preparation and immunohistochemistry protocol for SMLM analyses of AZ protein clusters in a defined model synapse. Our protocol could be adapted to study protein arrangements at single-molecule resolution in other intact tissue preparations.